Egypt electricity minister leads high-level delegation to 65th IAEA General Conference    Ravaged by war, Syrian rebel area struggles with virus surge    Trump sues niece, New York Times over Pulitzer-winning tax story    China, US unveil separate big steps to fight climate change    At UN, Moon pushes peace with NKorea after missile tests    Seven female Afghan taekwondo athletes resettle in Australia    A comeback win will help boost the team's morale: Atletico's Suarez after Getafe win    Beating terrorism with progress    Dune    'Soul-crushing': US COVID-19 deaths are topping 1,900 a day    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    Egypt at UNGA: Lobbying for compromises    No more paper invoices    President Sisi says River Nile lifeline for Egyptians, slams Ethiopia's intransigence in GERD talks    Field Marshal Mohamed Hussein Tantawi: Military role model    Egypt's Sinai, Nile Delta connected    Egypt's stocks end in red on Tuesday as benchmark EGX 30 drops 1.98%    Egypt to host African Development Bank 2023 annual meetings    It's a shame: Barcelona's Araujo after Granada draw    UAE-based Alameda to invest around $318 mln in Egypt in five years    Egypt to be removed from England's red travel list on September 22    Jordan hosts energy meeting today to discuss transporting Egyptian gas to Lebanon    Russia permits airlines to resume flights from 49 cities to Egypt    Egypt's Abu Soma Development partners with KOMPASS Education    Sisi: coronavirus vaccines in Africa 'far less' than actual needs    Orange Egypt Introduces Amazon Prime Video    Tokyo Olympics: Cautious opening ceremony, shy start for Egyptians in competitions    Mallawi Museum in Upper Egypt holds recycling workshop for children during Eid Al-Adha    Egypt keen on stable tax policies to attract more investors: Finance Minister    Sudan declares state of emergency as water goes beyond Merowe Dam capacity    Niagara Falls illuminated in Egyptian flag to mark 23 July Revolution anniversary    Capital flows into EM keep recovering after March 2020 slump: Central Bank of Egypt    1 child orphaned every 12 seconds due to COVID-19-associated death: World Bank    Egypt, Japanese Olympic Committee discuss boosting sports cooperation    Ethiopia ready to resume dam talks with no legally binding agreements: Ethiopian official    US emphasises AU's role in mediating Ethiopian damdispute    Sunken city of Thônis-Heracleion in Egypt's Abu Qir bay yields new archaeological treasures    New films, concerts, and destinations for Eid Al-Adha holidays    Egypt, Oman discuss enhancing bilateral economic, investment relations    Al Ahly v Kaizer Chiefs: Cairo giants eye 10th CAF Champions League title    Tunisia hopes to have a UN role in resolving Egypt-Ethiopia dam dispute    Egypt denounces Ethiopia's move to start second filling of giant dam    APO Group enters new exclusive agreement with Getty Images on African press releases and images    On International Museum Day, Egypt opens two new museums at Cairo Airport    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



EU takes on AstraZeneca in court over vaccine deliveries
Published in Ahram Online on 26 - 05 - 2021

The European Union took on vaccine producer AstraZeneca in a Brussels court on Wednesday with the urgent demand that the company needs to make an immediate delivery of COVID-19 shots the bloc insists were already due.
AstraZeneca's contract signed with the European Commission, the EU's executive arm, on behalf of member states foresaw an initial 300 million doses for distribution among all 27 countries, with an option for a further 100 million. The doses were expected to be delivered throughout 2021. But only 30 million were sent during the first quarter.
Deliveries have increased slightly since then but, according to the European Commission, the company is set to provide only 70 million doses in the second quarter. It had promised 180 million.
EU lawyer Rafael Jafferali told the court that the company now expects to deliver the total number of doses by the end of December, but he added that ``with a six-month delay, it's obviously a failure.``
His main argument is that AstraZeneca should have used production sites in the bloc and the UK for EU supplies as part of a ``best reasonable effort'' clause in the contract. He said that 50 million doses that should have been delivered to the EU went to third countries instead, ``in violation'' of their contract.
Jafferali has said that the company should use all four plants listed in their contract for deliveries to the EU.
He also accused the company of misleading the European Commission by providing data lacking clarity on the delivery delays.
``The information provided by AstraZeneca did not allow us to fully understand the situation before mid-March 2021,'' he said.
The EU has insisted its gripes with the company are about deliveries only and has repeatedly said that it has no problems with the safety or quality of the vaccine itself. The shots have been approved by the European Medicines Agency, the EU's drug regulator.
While the bloc insists AstraZeneca has breached its contractual obligations, the company says it has fully complied with the agreement, arguing that vaccines are difficult to manufacture and it made its best effort to deliver on time.
Lawyers for the company will address the court later Wednesday.
As part of an advanced purchase agreement with vaccine companies, the EU said it invested 2.7 billion euros ($3.8 billion), including 336 million ($408 million), to finance the production of AstraZeneca's serum at four factories.
The long-standing dispute drew media attention for weeks earlier this year amid a deadly surge of coronavirus infections in Europe, when delays in vaccine production and deliveries hampered the EU's vaccination campaign.
Cheaper and easier to use than rival shots from Pfizer-BioNTech, the AstraZeneca vaccine developed with Oxford University was a pillar of the EU's vaccine rollout. But the EU's partnership with the firm quickly deteriorated amid accusations it favored its relationship with British authorities.
While the UK made quick progress in its vaccination campaign thanks to the AstraZeneca shots, the EU faced embarrassing complaints and criticism for its slow start.
Concerns over the pace of the rollout across the EU grew after AstraZeneca said it couldn't supply EU members with as many doses as originally anticipated because of production capacity limits.
The health situation has dramatically improved in Europe in recent weeks, with the number of COVID-19 hospitalizations and deaths on a sharp downward trend as vaccination has picked up. About 300 million doses of vaccine have been delivered in Europe ,a region with around 450 million inhabitants, with about 245 million already administered.
About 46% of the EU population have had at least one dose.
In total, the European Commission has secured more than 2.5 billion of vaccine doses with various manufacturers. It recently sealed another major order with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses of their COVID-19 shot to share between the bloc's countries.
Following Wednesday's hearing, a second one is slated for Friday, with a judgment to be delivered at a date to be announced. In addition to the emergency action, the European Commission has launched a claim on the merits of the case for damages for which a hearing hasn't yet been set by the court.


Clic here to read the story from its source.